Related Experiment Video
Updated: Jul 13, 2026

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
Published on: August 2, 2022
Availability of blood components and plasma derived medicines in Iran
1Department of Pharmacology, University of Baqiyatallah Medical Sciences and Iranian Blood Transfusion Organization Research Center, Tehran, Iran. cheraghali@ibto.ir
Abstract:
Iran is a country with advanced health care system. In 1974 government of Iran established a centralized transfusion system. Since then donations of blood may not be remunerated and therapy with blood and its components is free of charge for all Iranian patients in need of the treatment. Most of donors in Iran are educated middle age men. In 2005 Iranian donated more than 1.6 millions units of blood. Although Iran population has doubled in past three decades blood donation has increased several folds. Donations are meticulously screened through interviewing of donors and lab testing of the donations using serological methods. In contrary to blood and blood components, Iran is heavily depends on importation of plasma derived medicines. Irrational use of blood components and low surveillance on use of plasma derived medicines, which are highly subsidized by the government, is a major challenge in transfusion medicines in Iran.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Drug Distribution: Plasma Protein Binding
Composition of Blood Plasma
Drug Products: Biologics, Biosimilars and Interchangeables

